These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 19212958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
    Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM.
    J Proteome Res; 2011 Jan 07; 10(1):143-52. PubMed ID: 20672848
    [Abstract] [Full Text] [Related]

  • 3. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N, Lee YC.
    Glycobiology; 2004 Mar 07; 14(3):275-92. PubMed ID: 14693911
    [Abstract] [Full Text] [Related]

  • 4. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D, Haberger M, Falck D, Peter B, Maier B, Gassner J, Hook M, Wagner K, Bonnington L, Bulau P, Wuhrer M.
    MAbs; 2015 Mar 07; 7(4):732-42. PubMed ID: 25996192
    [Abstract] [Full Text] [Related]

  • 5. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
    Goetze AM, Liu YD, Zhang Z, Shah B, Lee E, Bondarenko PV, Flynn GC.
    Glycobiology; 2011 Jul 07; 21(7):949-59. PubMed ID: 21421994
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS.
    Curr Opin Immunol; 2008 Aug 07; 20(4):471-8. PubMed ID: 18606225
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Selman MH, McDonnell LA, Palmblad M, Ruhaak LR, Deelder AM, Wuhrer M.
    Anal Chem; 2010 Feb 01; 82(3):1073-81. PubMed ID: 20058878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation.
    Sénard T, Gargano AFG, Falck D, de Taeye SW, Rispens T, Vidarsson G, Wuhrer M, Somsen GW, Domínguez-Vega E.
    Front Immunol; 2020 Feb 01; 11():2049. PubMed ID: 32973813
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure analysis of N-glycoproteins.
    Henning S, Peter-Katalinić J, Pohlentz G.
    Methods Mol Biol; 2009 Feb 01; 492():181-200. PubMed ID: 19241033
    [Abstract] [Full Text] [Related]

  • 18. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples.
    Reusch D, Haberger M, Selman MH, Bulau P, Deelder AM, Wuhrer M, Engler N.
    Anal Biochem; 2013 Jan 15; 432(2):82-9. PubMed ID: 23026777
    [Abstract] [Full Text] [Related]

  • 19. Assessing Fc glycan heterogeneity of therapeutic recombinant monoclonal antibodies using NP-HPLC.
    Raju TS.
    Methods Mol Biol; 2013 Jan 15; 988():169-80. PubMed ID: 23475719
    [Abstract] [Full Text] [Related]

  • 20. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
    Selman MH, Derks RJ, Bondt A, Palmblad M, Schoenmaker B, Koeleman CA, van de Geijn FE, Dolhain RJ, Deelder AM, Wuhrer M.
    J Proteomics; 2012 Feb 02; 75(4):1318-29. PubMed ID: 22120122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.